Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07011836 · ClinicalTrials.gov registry record · NA

Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women

A NA study of Uterine Cervical Neoplasms, sponsored by ISA Associates.

Recruiting
Registry status
NA
Development phase
288
Enrollment target
2
Study locations

NCT07011836: Recruiting NA study of Uterine Cervical Neoplasms, sponsored by ISA Associates.

NCT07011836 is a NA study of Uterine Cervical Neoplasms that is actively recruiting participants, run by ISA Associates. The registered enrollment target is 288 participants, below the 5,517-participant average among 8 other Uterine Cervical Neoplasms trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07011836, a NA study of Uterine Cervical Neoplasms, is actively recruiting participants, sponsored by ISA Associates.

RECRUITING
Registry status
NA
Development phase
288 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to test whether an interactive, video-based patient navigation program can improve cervical cancer screening among African American women who are currently overdue for screening. The main questions it aims to answer are: Can an interactive video navigation tool (mNav), when paired with in-person navigation, improve screening adherence compared to a standard educational video alone? Does the intervention improve knowledge, reduce barriers, and increase intentions to get screened? Researchers will compare participants who receive both the interactive video (guided by an on-screen navigator) and in-person navigation to those who receive only a standard educational video to see if the tailored support increases screening rates. Participants will: Complete two phone surveys (one at the beginning and one six months later) Be randomly assigned to one of two groups: One group will receive an interactive video experience tailored to their concerns plus support from an in-person navigator The other group will receive a standard educational video designed for African American women Have their clinic records reviewed six months later to check for cervical cancer screening completion

Primary Outcome

Whether participants completed cervical cancer screening, as verified through medical record review. Screening includes a Pap test, HPV test, or co-test, consistent with current guidelines.

Conditions Studied

Interventions

  • BEHAVIORAL Educational Video
  • BEHAVIORAL mNav Interactive Video + Navigator

Study Locations (2)

District of Columbia

  • Family and Medical Counseling Service, Inc. - Washington D.C.

Virginia

  • ISA Associates - Arlington

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2025-06-24
Est. Completion 2026-06-30
Phase NA
ISA Associates

6 total trials

What NCT07011836 shows while recruiting

NCT07011836 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 5,517-participant average among 8 other Uterine Cervical Neoplasms trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Uterine Cervical Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Educational Video is the first listed.

NCT07011836 reports a single indexed study location in District of Columbia, Virginia.

Frequently Asked Questions

What is clinical trial NCT07011836 about?

NCT07011836 is a clinical study titled "Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women". The goal of this clinical trial is to test whether an interactive, video-based patient navigation program can improve cervical cancer screening among African American women who are currently overdue for screening. The main questions it aims to answer are: Can an interactive video navigation tool (...

What is the current status of trial NCT07011836?

This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2025-06-24. Estimated completion is 2026-06-30.

What conditions does trial NCT07011836 study?

This clinical trial studies the following conditions: Uterine Cervical Neoplasms.

What interventions are being tested in trial NCT07011836?

The interventions under investigation include: Educational Video (BEHAVIORAL), mNav Interactive Video + Navigator (BEHAVIORAL).

Who is sponsoring clinical trial NCT07011836?

This trial is sponsored by ISA Associates, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07011836 being conducted?

This trial has 2 study locations across District of Columbia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Uterine Cervical Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07011836's enrollment target sits among peer trials

288 6th of 8 higher than 3 of 8 other Uterine Cervical Neoplasms trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Uterine Cervical Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02098265 · 288 participants · NA

    A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

  • NCT03741777 · 288 participants · NA

    Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume

  • NCT03937635 · 288 participants · Phase 3

    Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • NCT04621877 · 288 participants · NA

    Lay-Delivered Behavioral Activation in Senior Centers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07011836, the US trial registry maintained by the National Library of Medicine. NCT07011836 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.